Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine. - Wikidata - awgldk - TriplyDB

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.

http://www.wikidata.org/entity/Q34700580

about

Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists Optimal Use of Vaccines for Control of Influenza A Virus in Swine Reverse Genetics Approaches for the Development of Influenza Vaccines Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine An evaluation of the emerging vaccines against influenza in children.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species.Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs.Vaccine development for protecting swine against influenza virus.Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner.Rapid development of an efficacious swine vaccine for novel H1N1 Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses Innate immune evasion strategies of influenza viruses Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses Vaccination of influenza a virus decreases transmission rates in pigs Oral Fluids as a Live-Animal Sample Source for Evaluating Cross-Reactivity and Cross-Protection following Intranasal Influenza A Virus Vaccination in Pigs.The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine.Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populations Genome plasticity of triple-reassortant H1N1 influenza A virus during infection of vaccinated pigs.An eight-segment swine influenza virus harboring H1 and H3 hemagglutinins is attenuated and protective against H1N1 and H3N2 subtypes in pigs.Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v.Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.Animal models for the study of influenza pathogenesis and therapy.Epidemic status of Swine influenza virus in china.Swine influenza vaccines: current status and future perspectives.Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.Structural and functional analysis of NS1 and NS2 proteins of H1N1 subtype.The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells.

P2860

Q26745547-444D4A0C-B4CA-4867-B771-BAA4D55BC4EB Q26783503-2F35782D-0D1C-4766-8053-F2D56DC550AC Q28076140-69FDE72D-5856-4212-9439-DE835C4E098F Q28395006-13DB33E9-7DA8-457B-9A1E-3638B9E807E5 Q30234558-DD3DB231-5D4C-4706-B375-C9C2D50F8689 Q30359375-893621B9-FA5A-4537-8FA4-37B796128497 Q30373784-7A0D0933-9D53-43BD-A831-E45C047DA212 Q30377447-A66B7D22-6C6A-41E0-A4F5-3C6B558947A1 Q30378960-B5CF0302-8FCB-4305-904E-7F22704A835B Q30384443-09A63991-5DB8-4062-AC37-400213DA29E4 Q30384724-34BA198F-CACB-45F3-B595-59AEBCEC0DCC Q30388110-D740EA13-8D50-4AFE-A94B-8B5E2F59A101 Q30394706-8FDB9F98-4785-45DD-A8CB-EE2D13723BF6 Q30395088-1D1D596E-9232-4002-A9C3-1EA673F47EAA Q30407424-DEF26135-3DD5-447F-BF38-D95508D4A60E Q30419702-9E996FE5-1447-471B-BF99-B60F1E91953F Q30424943-29421FDF-B5B8-4F50-9403-192AF84AF012 Q30429134-0AD57575-DB9E-4983-BE1C-E34D8EEE87A2 Q33520451-0CD612AD-0B37-4178-8144-BACDD2BF0DE6 Q33614507-6B6046A5-76C2-4AF1-8D7D-5CA324EA6ECF Q33646273-F891B1A9-A92E-4E2F-B347-F773B693C2D6 Q33794563-C1EE2417-9EF8-4ACC-90E3-CD1110A46353 Q35672385-2E377201-1F65-428B-97BB-5A83ED98244B Q36087562-F97222BB-0F5C-4482-8434-7B3CC18E192A Q36146504-2B0267DB-605F-493A-A66A-52B8EBB9DFA3 Q36276647-865A1713-973B-418A-9A3C-6D3465B83A76 Q36276683-BC474377-4BC0-4115-85A1-AAF2EB95C9B1 Q36501567-D8541453-3E00-44CC-820B-E3EDE9C28F45 Q36871866-77224382-2443-4C80-8BA6-8C4712E3FB9B Q37123091-11AD971C-4804-4D2A-BD44-46D1815DEDD3 Q37123473-BBA204A1-168A-410E-8E97-62F2D5A27F28 Q37127910-15716AA9-B558-46D2-85B6-473232DD4003 Q37356103-2D926581-956C-450B-93B6-31899C9CF80A Q37379466-754011D2-FE97-428C-A536-4EE21C2360EC Q37470805-D6EDF3B6-CAFF-4EE4-99B0-299F213BFB1B Q37749889-B3CDADB5-A8CB-4162-8C53-2BD077AAA258 Q38727207-6D49F27F-C1F5-4C13-AAEA-7EA3872FFBEE Q39745470-30B9847F-A411-4CF6-9207-FF8B2E4D9998 Q41358125-D152563F-2434-4E57-8B05-FEC4075F027C Q41361470-6A020D08-EEEF-4920-BF65-D8E9262367CB

P2860

Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.

http://www.wikidata.org/entity/Q34700580

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@ast

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@en

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@nl

type

label

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@ast

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@en

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@nl

prefLabel

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@ast

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@en

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@nl

P1433

Q34700580-B4150D36-7B7A-4CFE-A57A-1E421E375A73

P1476

Q34700580-D78019F2-5A7A-4953-BCA2-FFC217B19650

P2093

Q34700580-11CD3DAB-7E39-449C-928F-469E55FEB69B

Q34700580-18EC523C-151B-44AB-8BD7-ECB4DE7AD294

Q34700580-78337BB8-B969-455D-AF8C-FA636639F12A

Q34700580-A2E0AD7E-6D7E-421F-A29A-14830480BEED

Q34700580-BCC8C7C8-08C3-4108-B9B9-4474EA9F1708

P2860

Q34700580-00002843-669F-456E-A7AF-1A7F972A3A30

Q34700580-015BBF50-A439-4431-B68C-6C6DF6DFA5FF

Q34700580-034F40DD-734F-4CDA-9305-AE4BB7003344

Q34700580-07E56E6A-35FB-4C8A-8E81-A3119AF47EEF

Q34700580-10C0A6AA-C549-4AFC-AD0F-AC32015140E5

Q34700580-1176515E-2F33-4B3A-BD3B-FBA8AA3FDEDF

Q34700580-13CA9602-BB47-4ECC-A125-0B17309839A5

Q34700580-1F2D9543-EA00-4420-B61B-4A1C4C2E6BFE

Q34700580-20BDA771-E4F4-44B0-8DDA-F62F0DDE5344

Q34700580-2ECF73D1-4D1B-4C56-9216-2FEC607247E6

P304

Q34700580-378F83D0-53D8-4B41-B561-D4263B58261D

P31

Q34700580-EEEBAA1B-C844-4C4B-B304-BBA447A47407

P356

Q34700580-C91E9722-2EEC-4A72-BA13-36921F2ACCEF

P407

Q34700580-E3D9EE19-1B5D-40B8-B7B6-57425310F105

P433

Q34700580-A8F07E2D-71DE-409C-9C6A-D1FF4565E7BB

P478

Q34700580-46EB9FA4-DE79-4BC8-9606-AE38D63ADAF2

P50

Q34700580-6C39FC38-EFFD-40CB-9BBC-DB5553816AAA

Q34700580-952673D3-88B0-44A9-BB5E-7F9B2D83877A

P577

Q34700580-767E6B80-6C7F-4C78-9800-4998BA5A3FDA

P5875

Q34700580-F964BD38-A8F6-4421-B3C5-64ED792CD61A

P698

Q34700580-271247F6-FA4C-4004-A432-FAEB419114C4

P932

Q34700580-37D9E13C-8060-4566-BEF4-6DCB20D66F30

P356

J.VACCINE.2007.09.019

P1433

P1476

Efficacy of intranasal adminis ...... luenza virus vaccine in swine.

@en

P2093

Amy L Vincent

http://www.w3.org/2001/XMLSchema#string

Bruce H Janke

http://www.w3.org/2001/XMLSchema#string

Jürgen A Richt

http://www.w3.org/2001/XMLSchema#string

Kelly M Lager

http://www.w3.org/2001/XMLSchema#string

Wenjun Ma

http://www.w3.org/2001/XMLSchema#string

P2860

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

Phylogenetic analysis of H1N2 isolates of influenza A virus from pigs in the United States

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

Multiple lineages of antigenically and genetically diverse influenza A virus co-circulate in the United States swine population.

Cell-mediated protection in influenza infection.

Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses

Genetic reassortment of avian, swine, and human influenza A viruses in American pigs.

Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs.

Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States.

P304

7999-8009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2007.09.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

47

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Adolfo García-Sastre

P577

2007-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5912683

http://www.w3.org/2001/XMLSchema#string

P698

17933442

http://www.w3.org/2001/XMLSchema#string

P932

2099695

http://www.w3.org/2001/XMLSchema#string